• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压性心脏病的多模态影像学价值。

The value of multimodality imaging in hypertensive heart disease.

机构信息

Department of Heart Disease, Haukeland University Hospital, Bergen, Norway.

Department of Cardiology, University Hospital 'Dr Dragisa Misovic - Dedinje', Heroja Milana Tepica, Belgrade, Serbia.

出版信息

J Hypertens. 2021 May 1;39(5):1040-1043. doi: 10.1097/HJH.0000000000002726.

DOI:10.1097/HJH.0000000000002726
PMID:33239554
Abstract

Hypertensive heart disease (HHD) includes left ventricular (LV) functional and structural remodeling. For a long time, this involved only LV diastolic dysfunction and LV hypertrophy. However, development of imaging technique enabled more detailed insights into LV mechanics. Its impairment seems to be the first step in the cascade of HHD. Tissue characterization, obtained by cardiac magnetic resonance, opened a completely new chapter in the assessment of HHD. We report a case of a 47-year-old man who was referred to our department for a newly detected heart failure. CT angiography excluded relevant coronary disease and cardiac magnetic resonance revealed focuses of fibrosis in interventricular septum, in addition severely dilated LV with severely reduced ejection fraction. Considering the fact that the patient had longstanding uncontrolled arterial hypertension and that other causes of cardiac remodeling and dysfunction were excluded, we hypothesized that the multimodality imaging approach enabled prompt diagnosis of HHD.

摘要

高血压性心脏病(HHD)包括左心室(LV)功能和结构重塑。长期以来,这只涉及 LV 舒张功能障碍和 LV 肥厚。然而,成像技术的发展使我们能够更详细地了解 LV 力学。它的损伤似乎是 HHD 级联反应的第一步。心脏磁共振获得的组织特征为 HHD 的评估开辟了全新篇章。我们报告了一例 47 岁男性患者,因新发现的心力衰竭而被转诊至我科。CT 血管造影排除了相关的冠状动脉疾病,心脏磁共振显示室间隔有纤维灶,此外 LV 严重扩张,射血分数严重降低。考虑到患者患有长期未控制的动脉高血压,且排除了其他导致心脏重塑和功能障碍的原因,我们假设多模态成像方法能够快速诊断 HHD。

相似文献

1
The value of multimodality imaging in hypertensive heart disease.高血压性心脏病的多模态影像学价值。
J Hypertens. 2021 May 1;39(5):1040-1043. doi: 10.1097/HJH.0000000000002726.
2
Sensitive marker for evaluation of hypertensive heart disease: extracellular volume and myocardial strain.评估高血压性心脏病的敏感标志物:细胞外体积和心肌应变。
BMC Cardiovasc Disord. 2020 Jun 15;20(1):292. doi: 10.1186/s12872-020-01553-7.
3
High prevalence of myocarditis in patients with hypertensive heart disease and cardiac deterioration.高血压性心脏病患者心肌炎症发生率高,且心脏恶化。
Eur J Heart Fail. 2013 Mar;15(3):284-91. doi: 10.1093/eurjhf/hfs169. Epub 2012 Oct 30.
4
Phenotyping the hypertensive heart.高血压心脏表型。
Eur Heart J. 2022 Oct 11;43(38):3794-3810. doi: 10.1093/eurheartj/ehac393.
5
Cardiovascular diseases and systolic function of left ventricle in clean up workers of Chernobyl accident (based on 30 years follow up).切尔诺贝利事故清理工作人员的心血管疾病及左心室收缩功能(基于30年随访)
Probl Radiac Med Radiobiol. 2017 Dec;22:292-305.
6
[Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].[伴有左心室扩张和充血性心力衰竭的肥厚型心肌病:与心肌炎后心脏扩大和高血压性心力衰竭的比较]
J Cardiogr. 1983 Sep;13(3):537-50.
7
Cardiovascular magnetic resonance feature tracking strain analysis for discrimination between hypertensive heart disease and hypertrophic cardiomyopathy.心血管磁共振特征追踪应变分析在鉴别高血压性心脏病与肥厚型心肌病中的应用。
PLoS One. 2019 Aug 21;14(8):e0221061. doi: 10.1371/journal.pone.0221061. eCollection 2019.
8
Pathophysiology of Hypertensive Heart Disease: Beyond Left Ventricular Hypertrophy.高血压性心脏病的病理生理学:超越左心室肥厚。
Curr Hypertens Rep. 2020 Feb 3;22(2):11. doi: 10.1007/s11906-020-1017-9.
9
Progressive impairment of atrial myocyte function during left ventricular hypertrophy and heart failure.左心室肥厚和心力衰竭过程中心房肌细胞功能进行性损伤。
J Mol Cell Cardiol. 2018 Jan;114:253-263. doi: 10.1016/j.yjmcc.2017.11.020. Epub 2017 Dec 2.
10
Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH).一项多中心、随机、安慰剂对照试验的基本原理和设计,该试验评估米拉贝隆(一种β3-肾上腺素能受体激动剂)对结构性心脏病患者左心室质量和舒张功能的影响,研究对象为β3-左心室肥厚(β3-LVH)患者。
ESC Heart Fail. 2018 Oct;5(5):830-841. doi: 10.1002/ehf2.12306. Epub 2018 Jun 22.